Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone

Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) mediate the degradation of acetylcholine (ACh), a primary neurotransmitter in the brain. Cholinergic deficiency occurs during the progression of Alzheimer’s disease (AD), resulting in widespread cognitive dysfunction and decline. We evalua...

Full description

Bibliographic Details
Main Authors: Jayeong Hwang, Kumju Youn, Yeongseon Ji, Seonah Lee, Gyutae Lim, Jinhyuk Lee, Chi-Tang Ho, Sun-Hee Leem, Mira Jun
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/5/1215
_version_ 1797569646885339136
author Jayeong Hwang
Kumju Youn
Yeongseon Ji
Seonah Lee
Gyutae Lim
Jinhyuk Lee
Chi-Tang Ho
Sun-Hee Leem
Mira Jun
author_facet Jayeong Hwang
Kumju Youn
Yeongseon Ji
Seonah Lee
Gyutae Lim
Jinhyuk Lee
Chi-Tang Ho
Sun-Hee Leem
Mira Jun
author_sort Jayeong Hwang
collection DOAJ
description Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) mediate the degradation of acetylcholine (ACh), a primary neurotransmitter in the brain. Cholinergic deficiency occurs during the progression of Alzheimer’s disease (AD), resulting in widespread cognitive dysfunction and decline. We evaluated the potential effect of a natural cholinesterase inhibitor, zerumbone, using in vitro target enzyme assays, as well as in silico docking and ADMET (absorption, distribution, metabolism, excretion, and toxicity) simulation. Zerumbone showed a predominant cholinesterase inhibitory property with IC<sub>50</sub> values of 2.74 ± 0.48 µM and 4.12 ± 0.42 µM for AChE and BChE, respectively; however, the modes of inhibition were different. Computational docking simulation indicated that Van der Waals interactions between zerumbone and both the cholinesterases were the main forces responsible for its inhibitory effects. Furthermore, zerumbone showed the best physicochemical properties for both bioavailability and blood–brain barrier (BBB) permeability. Together, in the present study, zerumbone was clearly identified as a unique dual AChE and BChE inhibitor with high permeability across the BBB, suggesting a strong potential for its physiological benefits and/or pharmacological efficacy in the prevention of AD.
first_indexed 2024-03-10T20:13:44Z
format Article
id doaj.art-85e00c535482489ba6a542c9eb789b51
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T20:13:44Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-85e00c535482489ba6a542c9eb789b512023-11-19T22:43:58ZengMDPI AGNutrients2072-66432020-04-01125121510.3390/nu12051215Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of ZerumboneJayeong Hwang0Kumju Youn1Yeongseon Ji2Seonah Lee3Gyutae Lim4Jinhyuk Lee5Chi-Tang Ho6Sun-Hee Leem7Mira Jun8Department of Food Science and Nutrition, Dong-A University, Busan 49315, KoreaDepartment of Food Science and Nutrition, Dong-A University, Busan 49315, KoreaDepartment of Food Science and Nutrition, Dong-A University, Busan 49315, KoreaDepartment of Food Science and Nutrition, Dong-A University, Busan 49315, KoreaKorean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, KoreaKorean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, KoreaDepartment of Food Science, Rutgers University, New Brunswick, NJ 08901, USADepartment of Biological Science, Dong-A University, Busan 49315, KoreaDepartment of Food Science and Nutrition, Dong-A University, Busan 49315, KoreaAcetylcholinesterase (AChE) and butyrylcholinesterase (BChE) mediate the degradation of acetylcholine (ACh), a primary neurotransmitter in the brain. Cholinergic deficiency occurs during the progression of Alzheimer’s disease (AD), resulting in widespread cognitive dysfunction and decline. We evaluated the potential effect of a natural cholinesterase inhibitor, zerumbone, using in vitro target enzyme assays, as well as in silico docking and ADMET (absorption, distribution, metabolism, excretion, and toxicity) simulation. Zerumbone showed a predominant cholinesterase inhibitory property with IC<sub>50</sub> values of 2.74 ± 0.48 µM and 4.12 ± 0.42 µM for AChE and BChE, respectively; however, the modes of inhibition were different. Computational docking simulation indicated that Van der Waals interactions between zerumbone and both the cholinesterases were the main forces responsible for its inhibitory effects. Furthermore, zerumbone showed the best physicochemical properties for both bioavailability and blood–brain barrier (BBB) permeability. Together, in the present study, zerumbone was clearly identified as a unique dual AChE and BChE inhibitor with high permeability across the BBB, suggesting a strong potential for its physiological benefits and/or pharmacological efficacy in the prevention of AD.https://www.mdpi.com/2072-6643/12/5/1215ADMETAlzheimer’s disease (AD)cholinesterasescomputational docking simulationzerumbone
spellingShingle Jayeong Hwang
Kumju Youn
Yeongseon Ji
Seonah Lee
Gyutae Lim
Jinhyuk Lee
Chi-Tang Ho
Sun-Hee Leem
Mira Jun
Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
Nutrients
ADMET
Alzheimer’s disease (AD)
cholinesterases
computational docking simulation
zerumbone
title Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
title_full Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
title_fullStr Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
title_full_unstemmed Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
title_short Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
title_sort biological and computational studies for dual cholinesterases inhibitory effect of zerumbone
topic ADMET
Alzheimer’s disease (AD)
cholinesterases
computational docking simulation
zerumbone
url https://www.mdpi.com/2072-6643/12/5/1215
work_keys_str_mv AT jayeonghwang biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT kumjuyoun biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT yeongseonji biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT seonahlee biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT gyutaelim biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT jinhyuklee biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT chitangho biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT sunheeleem biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone
AT mirajun biologicalandcomputationalstudiesfordualcholinesterasesinhibitoryeffectofzerumbone